A global map showing current efficacy trial countries and their status of PrEP implementation.
Where Does Oral PrEP Fit in to Vaccine and AMP Trials?
Vaccine Approaches in Early-Phase Development
An outline of various approaches to vaccine development that are in earlier phase research, e.g., phase I or II trials; development pathways for these candidates are uncertain at this time.
Vaccines and Antibodies on Efficacy Pathways
A timeline of current efficacy programs for vaccines and antibodies, highlighting the P5 program testing pox-protein candidates, the Janssen program testing mosaic-based candidates, and the AMP studies testing the antibody VRC01.
Trial Participants by Prevention Research Area, 2015
Given the higher rates of acquisition seen across so-called key populations—members of highly burdened and underserved groups—it is critical to provide access to the research process such that they can participate and reap more immediate benefit of scientific progress. Greater efforts must be made to include key populations in this crucial process for the HIV prevention response to be truly impactful.
Global HIV Prevention R&D Investments by Technology, 2000-2015
In 2015, global funding for HIV prevention R&D declined slightly, from US $1.25 billion in 2014 to US $1.20 billion in 2015. This continues a decade of roughly flat funding. The US public sector remained the largest global contributor at US $850 million, and together with the Bill & Melinda Gates Foundation, the largest philanthropic funder, constituted 81 percent of all funding.
Biomedical Prevention in 2016 – At a Glance
A snapshot of prevention strategies underway or under development from 2015-2020. Excerpted from AVAC Report 2016: Big Data, Real People.
HIV Prevention Research Status Report
A survey of prevention strategies and the status of their safety and efficacy. Excerpted from AVAC Report 2016: Big Data, Real People.
Progress Toward an Vaccines
This one-page infographic from NIAID highlights challenges and progress in the search for a vaccines, and also includes brief descriptions of some of the approaches to vaccine development that scientists are exploring today.
Vaccines Clinical Trials Snapshot
Excerpted from our quick, colorful and comprehensive vaccines research four-pager, the centerspread tracks the current status and future possibilities of all potential vaccines approaches being test. The centerspread also has a list of what advocates’ should be on the lookout for.
bNAb Targets on HIV
Scientists have mapped the shape and structure of bNAbs and identified points of contact and binding with the envelope trimer, shown in this graphic. Understanding the shape of the binding sites for bNAbs is key to vaccine development.